tiprankstipranks
Advertisement
Advertisement

HK:9877 Stock Latest News

Jenscare Wins EU MDR CE Mark for LuX-Valve Plus, Advancing Global Heart-Device Push
Company AnnouncementsJenscare Wins EU MDR CE Mark for LuX-Valve Plus, Advancing Global Heart-Device Push
3d ago
9877
Jenscare Wins Hong Kong Approval for Ken-Valve Heart Valve System
PremiumCompany Announcements
Jenscare Wins Hong Kong Approval for Ken-Valve Heart Valve System
19d ago
9877
Jenscare Scientific Reports Poll Results and High Turnout at 2025 AGM
PremiumCompany Announcements
Jenscare Scientific Reports Poll Results and High Turnout at 2025 AGM
1M ago
9877
Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients
PremiumCompany Announcements
Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients
2M ago
9877
Jenscare Scientific Calls 2025 AGM and Seeks Mandate for New Financing
PremiumCompany Announcements
Jenscare Scientific Calls 2025 AGM and Seeks Mandate for New Financing
2M ago
9877
Jenscare’s iJensRobo Heart Valve Robot Completes First Clinical Study in Hong Kong
PremiumCompany AnnouncementsJenscare’s iJensRobo Heart Valve Robot Completes First Clinical Study in Hong Kong
3M ago
9877
Jenscare Scientific Posts First Commercial Revenue as Global Valve Portfolio Advances
Premium
Company Announcements
Jenscare Scientific Posts First Commercial Revenue as Global Valve Portfolio Advances
4M ago
9877
Jenscare Restructures Finance Leadership and Streamlines Company Secretarial Role
Premium
Company Announcements
Jenscare Restructures Finance Leadership and Streamlines Company Secretarial Role
4M ago
9877
Jenscare Scientific Schedules Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Jenscare Scientific Schedules Board Meeting to Approve 2025 Annual Results
4M ago
9877
Jenscare Wins New Zealand Approval for Key Transcatheter Heart Valves
PremiumCompany Announcements
Jenscare Wins New Zealand Approval for Key Transcatheter Heart Valves
5M ago
9877
Jenscare Wins FDA Green Light for Pivotal U.S. Trial of LuX-Valve Plus
PremiumCompany Announcements
Jenscare Wins FDA Green Light for Pivotal U.S. Trial of LuX-Valve Plus
5M ago
9877
Jenscare Projects Up to RMB110 Million in First-Year Commercial Revenue on Strong Ken-Valve Uptake
PremiumCompany Announcements
Jenscare Projects Up to RMB110 Million in First-Year Commercial Revenue on Strong Ken-Valve Uptake
6M ago
9877
Jenscare Scientific Shareholders Back Sweeping Governance Changes at 2025 Extraordinary Meeting
PremiumCompany AnnouncementsJenscare Scientific Shareholders Back Sweeping Governance Changes at 2025 Extraordinary Meeting
6M ago
9877
Jenscare Seeks CE Mark for JensClip Mitral Valve Repair System in Global Push
Premium
Company Announcements
Jenscare Seeks CE Mark for JensClip Mitral Valve Repair System in Global Push
6M ago
9877
Jenscare Scientific Cancels Book Closure Period for H Shares
Premium
Company Announcements
Jenscare Scientific Cancels Book Closure Period for H Shares
7M ago
9877
Jenscare Scientific Proposes Governance Restructuring
PremiumCompany Announcements
Jenscare Scientific Proposes Governance Restructuring
7M ago
9877
Jenscare Scientific Announces 2025 Extraordinary General Meeting
PremiumCompany Announcements
Jenscare Scientific Announces 2025 Extraordinary General Meeting
7M ago
9877
Jenscare Scientific Announces Book Closure for 2025 EGM
PremiumCompany Announcements
Jenscare Scientific Announces Book Closure for 2025 EGM
7M ago
9877
Jenscare Scientific’s LuX-Valve Plus Shows Promising Results in Large Annulus Patients
PremiumCompany Announcements
Jenscare Scientific’s LuX-Valve Plus Shows Promising Results in Large Annulus Patients
8M ago
9877
Jenscare Scientific Clarifies Safety Results in Recent Announcements
PremiumCompany AnnouncementsJenscare Scientific Clarifies Safety Results in Recent Announcements
8M ago
9877
Jenscare Scientific Unveils Promising Clinical Results at TCT 2025
Premium
Company Announcements
Jenscare Scientific Unveils Promising Clinical Results at TCT 2025
8M ago
9877
Jenscare Scientific Unveils Promising Clinical Results at TCT 2025
Premium
Company Announcements
Jenscare Scientific Unveils Promising Clinical Results at TCT 2025
9M ago
9877

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >